Warberg Asset Management’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,479
Closed -$62K 222
2025
Q1
$62K Sell
9,479
-6,845
-42% -$51.8K 0.01% 128
2024
Q4
$140K Buy
16,324
+12,798
+363% +$110K 0.02% 123
2024
Q3
$26.5K Buy
+3,526
New +$113K ﹤0.01% 151

Other funds holding VTAK

Warberg Asset Management's VTAK Position: Q2 2025 in Review

Warberg Asset Management sold out of Catheter Precision (VTAK) in Q2 2025, closing a stake of 9,479 shares — an estimated $62K sold.

Warberg Asset Management first reported a position in VTAK in Q3 2024 and held it in 3 quarters. The position peaked at $140K in Q4 2024. 12 funds tracked by Wall St. Rank hold VTAK as of Q2 2025.

  • Warberg Asset Management reported no remaining Catheter Precision position as of Q2 2025 after selling out during the quarter.
  • Warberg Asset Management sold 9,479 Catheter Precision shares in Q2 2025, an estimated $62K.
  • Warberg Asset Management first reported a position in Catheter Precision in Q3 2024 and held it in 3 quarters.
  • Warberg Asset Management's Catheter Precision position peaked at $140K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2025.

Based on Warberg Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.